Statistics from Altmetric.com
- MD, mesomelic dysplasia
- MDK, mesomelic dysplasia Kantaputra type
- PAC, P1 derived artificial chromosome
- STS, sequence tagged sites
Mesomelic dysplasia (MD) is characterised by mildly short stature and shortening of the middle segments of the limbs. There are several subtypes of MD including dyschondrosteosis (Leri-Weill type), Langer type, Nivergelt type, Robinow type, Reinhardt type, Kozlowski-Reardon type, Werner type, and mesomelic dysplasia with synostoses.1 Ventruto et al2 reported an Italian family in which four members with a type of MD and vertebral abnormalities had a balanced translocation t(2;8)(q32;p13), which turned out to be t(2;8)(q31;p21) using our improved banding techniques, but three other phenotypically normal members were karyotypically normal. Thus, this type of MD seemed causally related or linked to the translocation. The female proband in the family had a short forearm with bowed and malformed radius, cubitus valgus with limited extension and supination, Madelung-type wrist deformity, atlantoaxial fusion, spina bifida occulta in the lumbosacral region, and the translocation. Kantaputra et al3 reported a large Thai family with another type of MD, Kantaputra type (MDK), similar to but with more severe manifestations than the MD in the Italian patients. MDK showed mildly short stature, shortening of the forearm/lower leg, carpal/tarsal synostosis, and dorsolateral foot deviation. Our previous linkage analysis of the Thai family using positional information from the translocation breakpoints in the Italian family showed that chromosome 2q24-q32, spanning about a 22.7 cM region, is implicated in MDK.4 The analysis also suggested that both conditions in the two families are identical or allelic. Furthermore, the HOXD cluster that is related to limb development has been mapped to 2q31.5 This led us to characterise the 2q31 breakpoint in the Italian family. Here we report the results of the breakpoint analysis.
MATERIALS AND METHODS
Fluorescence in situ hybridisation (FISH)
FISH analysis using P1 derived artificial chromosome (PAC)/cosmid DNA was performed on metaphase chromosomes of a patient with the 2;8 translocation from the Italian family reported by Ventruto et al2 using standard methods.
Isolation of PACs and cosmids and construction of a cosmid contig
A RPCI-1, 3 PAC library was screened by PCR with primers each corresponding to HOXD3, 4, 8, 10, and 13, and EVX2 (GenBank accession numbers, XM_056998, XM_042818, NM_019558, NM_002148, NM_000523, and XM_065465, respectively). Cosmid sublibraries were prepared from genomic DNA of the patient as described elsewhere.6,7 Cosmid DNA was extracted by PI-100 DNA isolation system (Kurabo, Osaka, Japan). A total of 260 cosmid clones were randomly chosen and used for construction of a contig covering the breakpoint. The contig was constructed by means of STS content mapping using PCR. New sequence tagged sites (STSs) were generated from end sequences of isolated clones.
Isolation of cosmid clone spanning the translocation breakpoint
A cosmid library of the patient using SuperCos1 vector was prepared according the manufacturer's protocol (Stratagene, La Jolla, CA, USA). About a 4-genome-fold library was screened with two probes flanking the 2q31 breakpoint as described previously.7 These probes were prepared using the following two pairs of primers (5`-3`): 1f/1r, TAGAGGGA TGGCAAACTCAG/GCTCTACCATTAGTTAGAGG; 2f/2r, CCCAT TACCAGAACTTCGTGA/CCATAATCAAATTGCTTCCACA. The 1f/1r and 2f/2r later turned out to be 8.9 kb and 1.3 kb centromeric to the breakpoint, respectively.
DNA sequencing and computational analysis of sequences
PAC/cosmid DNA and PCR products were sequenced with ABI Prism Big Dye TerminatorTM Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems, Foster, CA, USA) as previously described.7 Products were analysed on ABI 377 or 310 automated sequencers (PE Applied Biosystems).
New STSs were generated from clone end sequences after excluding repetitive sequences, using Primer3 (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi). For analysis of entire cosmid/BAC sequences, RepeatMasker (http://ftp.genome.washington.edu/cgi-bin/RepeatMasker) was first used to eliminate repetitive sequences. PipMaker (http://bio.cse.psu.edu/pipmaker/) and Blast2 (http://www.ncbi.nlm.nih.gov/gorf/b12.html) analyses were performed to compare sequences flanking 2q31 and 8p21 breakpoints. HGMP-RC NIX Session (http://www.hgmp.mrc.ac.uk/Registered/Webapp/nix/) was used to detect potential genes, exons, and promoters around each breakpoint.
Isolation of PAC clones and construction of cosmid contig spanning the 2q31 breakpoint
A total of six PAC clones were isolated by PCR with the five sets of primers corresponding to five HOXD genes. Among them, four PAC clones (349J14, 395P15, 440D1, and 342A21) showed FISH signals only on the normal chromosome 2 and der(2) chromosome. The other two clones (424A2 and 216K8) gave FISH signals on both der(2) and der(8) chromosomes in addition to the normal chromosome 2. Thus, these two PAC clones spanned the breakpoint.
A complete cosmid contig was constructed by PCR based STS content mapping (fig 1). Besides STSs for the HOXD genes, 10 new STSs (c11T3, c18T3, c55T3, c79T7, c55T7, c181T3, c188T3, c21T7, c181T7, and c188T7) were generated from end sequences of cosmid subclones. FISH analysis showed that five cosmid subclones (c55, c50, c58, c21, and c251) were mapped centromeric to the 2q31 breakpoint, c183 distal to it, and two clones (c181 and c188) at the breakpoint (fig 2). Thus, the 2q31 breakpoint was localised between the two STSs, c188T3 and c181T7.
Cloning of a cosmid containing the 2q31 junction fragment
A cosmid library was constructed from genomic DNA of the patient and screened by hybridisation using two probes generated by PCR with primers 1f/1r and 2f/2r. Among two clones isolated, a 2q31 breakpoint junction clone BR was identified. The BlastN searches showed that this clone had both the T3 end sequence hitting RP11-437N19 (Genbank accession number AC016739.5, mapped to chromosome 2) and the T7 end sequence corresponding to RP11-219J21 (GenBank accession number AC073069.2, mapped to chromosome 8). Detailed partial sequence analyses showed that the clone contained chimaeric sequences and turned out to be from the der(2) chromosome. PCR using a primer set (BR2F, AGAATGTGGCAATGTGGTGA at 2q31 and BR8R, CTGTTAG GACAGAGAGCTCC at 8p21) designed to amplify a junction fragment of the der(2) chromosome successfully yielded a product on the patient's DNA but not on control DNA (data not shown).
Sequence comparison and characterisation of the 2q31 and the 8p21 breakpoints
PCR with a primer set (BR8F, AGATCACATATGCCAAAGGC at 8p21 and BR2R, ACACAGTGGAACAATCG at 2q31) that was designed to amplify the der(8) breakpoint successfully created a product only on the patient's DNA. Sequence analysis of the product showed chimaeric sequences derived from RP11-437N19 (chromosome 2) and RP11-219J21 (chromosome 8). All sequences from normal chromosomes 2 and 8, and der(2) and der(8) chromosomes were aligned (fig 3). The der(8) sequence had a deletion of two nucleotides, CA, and an insertion of 13 nucleotides, TGGATACTCTTAA, with unknown origin, whereas the der(2) chromosome had no nucleotide changes (fig 3). The PipMaker and Blast2 comparisons of sequences that flanked the 2q31 and the 8p21 breakpoints did not identify any similar or repetitive sequences.
HGMP-RC NIX Session (http://www.hgmp.mrc.ac.uk/Registered/Webapp/nix/) was used to detect potential genes, exons, and promoters around each breakpoint. Although there was no gene disrupted at the breakpoints, MTX2 (Genbank accession number 16161620) and the HOXD gene cluster (HOXD1) (Genbank accession number 16157968) were identified 21 kb telomeric and 56 kb centromeric to the 2q31 breakpoint, respectively. Sequence analysis of MTX2, HOXD9-13 of the patient did not show any nucleotide changes (data not shown). No gene was identified in a 430 kb region (230 kb centromeric and 200 kb telomeric) around the 8p21 breakpoint by the NIX session.
Since all four members affected with a type of MD in the Italian family2 carried a balanced t(2;8)(q31;p21), and all three other unaffected members were karyotypically normal, the a priori hypothesis of our study was that a putative gene responsible for the skeletal disease in the family was affected by the translocation. We have characterised the 2q31 and the 8p21 breakpoint sequences in one of the patients and have shown that no known genes or gene-like sequences were disrupted at either breakpoint. Instead, we identified the HOXD gene cluster and MTX2 which are 56 kb centromeric and 21 kb telomeric to the 2q31 breakpoint, respectively, and the 2q31 breakpoint was positively mapped within the linkage interval of the MDK family.4 We could not find any homology between sequences of chromosomes 2 and 8 flanking breakpoints,7 any repetitive sequences,8 nor any specific sequence structures possibly mediating constitutional translocations.9 MTX2 protein is probably involved in mitochondrial protein import, but its precise function remains to be investigated. Hoxd genes, as well as Hoxa genes, are known to play important roles in the body plan in the vertebrate. These findings suggested several possibilities, (1) an enhancer of the HOXD genes cluster was disrupted by the chromosomal translocation, (2) misregulation of the entire HOXD cluster by an ectopic regulatory element normally located on 8p21, (3) a position effect on these genes close to the breakpoints altered their expression, (4) a coincidental rare instance of a gene with a mutation close to the breakpoint, but no evidence of aberrant sequences of MTX2 and HOXD9-13 in the patient, (5) the effect of chance, although this is unlikely because the probability would be as low as 1/1024.
Hoxd genes along the main body axis are regulated separately to their expression in the limbs and genitalia.10–12 An enhancer responsible for the sequential activation of the Hoxd genes along the main body axis is located less than 28 kb upstream of the 5` end of the Hoxd cluster. Another enhancer, which appears to regulate the coordinated expression of the four most 5` Hoxd genes (Hoxd10-Hoxd13) and the adjacent Evx2 gene in the developing autopod and genital tubercle, is also thought to lie well upstream of the 5` end of the HoxD cluster.13,14 A spontaneous mouse mutant with mesomelic dysplasia, Ulnaless (Ul), has been mapped to the vicinity of the Hoxd cluster. The abnormalities in the Ul mouse are confined to the limbs and the penile bone. Moreover they are associated with reduced expression of the Hoxd13 and Hoxd12 in the developing autopod and genital tubercle, and ectopic expression of Hoxd13 and Hoxd12 in the developing zeugopod. They were therefore previously thought to result from a deletion or rearrangement of the digit enhancer. Abnormalities of MDK in the Thai family3 are also confined to the limbs, so they can be explained by a defect of digit enhancer.
The phenotype associated with the translocation in the family we described, however, includes abnormalities of the axial skeleton as well as the limbs. Moreover, the upper cervical as well as the lumbosacral vertebrae are affected, suggesting perturbation of 3` as well as 5` HOXD gene expression. These features cannot be explained only by an effect upon the digit enhancer. They may be the result of misregulation of the entire cluster by a regulatory element normally located on 8p21, although we do not have any clear evidence. Alternatively, they may be the result of removal/disruption of a hitherto unsuspected cis acting regulatory element for the entire cluster which is normally located downstream of the cluster's 3` end. Recently, it was shown that sequences responsible for regulating colinear Hoxd gene expression along the trunk are located within or close to the cluster itself, whereas sequences responsible for directing 5` Hoxd gene expression to the limbs and genitalia lie at least 100 kb upstream of the cluster's 5` end and/or at least 10 kb downstream of its 3` end.15 Thus it is possible that the 2q31 breakpoint which is 56 kb downstream of the 3` end of the HOXD cluster disrupts its unrecognised enhancer in humans.
Breakpoints of a balanced chromosomal translocation, t(2;8)(q31;p21), observed in four patients with mesomelic dysplasia (MD) and vertebral abnormalities in an Italian family which was described by Ventruto et al in 1983, were cloned and analysed.
One of the breakpoints, 2q31, had previously been implicated by our linkage analysis in mesomelic dysplasia, Kantaputra type (MDK). Dysplasia of the zeugopod in both the Italian and MDK patients suggested that the 2q31 region might harbour a gene(s) determining limb development.
Although no genes or gene-like sequences were found at either breakpoint, the HOXD gene cluster is located 56 kb centromeric to the 2q31 breakpoint. Sequence analysis of both breakpoints showed an insertion of 13 nucleotides of unknown origin and a loss of two nucleotides from the derivative chromosome 8, but no sequence change in the derivative chromosome 2.
Either disruption of an enhancer of the HOXD gene cluster by the chromosomal translocation or a position effect on those genes close to the breakpoints may explain the MD phenotype.
Position effect may be an alternative explanation. It is recognised as a change of gene expression by a chromosomal aberration with an intact transcriptional unit, has been reported in several diseases,16 and can alter the expression of a gene even 900 kb away from a breakpoint.17 Thus, given that the distance from the breakpoint to the HOXD cluster is only 56 kb, it is possible that position effect is playing a role in altering gene expression at this cluster.
In conclusion, the 2q31 breakpoint of the MD family was confirmed to be located 56 kb from the 3` end of the HOXD cluster. Their phenotype may be explained either by a defect of HOXD enhancer or position effect on the HOXD cluster because of the chromosomal translocation.
NOTE ADDED IN PROOF
Another paper on this subject18 was published after our work was accepted for publication. The two investigations were performed independently.
We would like to express our gratitude to Ms Yasuko Noguchi, Kazumi Miyazaki, Naoko Takaki, and Naoko Yanai for their technical assistance. We also thank Dr Eli Hatchwell at the Genome Research Center, Cold Spring Harbor Laboratory for critical reading of the manuscript, Dr Shiro Ikegawa at the Laboratory for Bone and Joint Diseases, SNP Research Centre, Riken, and Dr Kenjiro Kosaki at the Department of Paediatrics, Keio University School of Medicine for providing useful information on HOXD11 analysis. This work was supported by a grant, CREST, of the Japan Science and Technology Corporation (JST).
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.